The Effect of Groups II and III Metabotropic Glutamate Receptor Activation on Neuronal Injury in a Rodent Model of Traumatic Brain Injury

Abstract

Administration of selective Group II metabotropic glutamate receptor agonists protects neurons against in vivo TBI. These receptors may thus be a promising target for future neuroprotective drugs.